Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI help doctors better care for Two-Spirit métis patients?

NCT ID NCT07760675

Knowledge-focused Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether an AI-assisted simulation can help Ob/Gyn residents improve their ability to provide culturally safe, trauma-informed care to Two-Spirit Métis patients. Up to 90 residents across three Canadian universities will be randomly assigned to either a specialized cultural safety workshop or standard training, followed by the same AI-based exam. The goal is to see if this approach is feasible and whether it improves communication and cultural humility.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-assisted Objective Structured Clinical Examination (OSCE) with cultural safety training
What this could lead to
If successful, this could point toward better training methods that help doctors provide more respectful and culturally safe care to Two-Spirit Métis patients.
What could go wrong
This is a small feasibility study, so results may not be conclusive. The AI simulation may not fully capture real-world interactions, and training effects might not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Current enrollment in an accredited Obstetrics and Gynecology residency program at one of the participating institutions (University of Alberta, University of Manitoba, or University of Saskatchewan). \* Postgraduate Year 1 through 5 (PGY1-PGY5). \* Fluency in English to ensure comprehension of AI-based encounters. \* Willingness and ability to participate fully in both the Academic Half Day and AI-assisted OSCE assessments. \* Provision of informed consent. Exclusion Criteria: * Prior participation (within 12 months) in Two-Spirit (2S) Métis-specific or similar cultural safety OSCEs or workshops. \* Residents not enrolled in participating Ob/Gyn residency programs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cultural competency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cultural competency Cultural safety Medical education

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Alberta

    Edmonton, Alberta, T6G 2C8, Canada

  • University of Manitoba

    Winnipeg, Manitoba, R3E 3P5, Canada

  • University of Saskatchewan

    Saskatoon, SA, S7N 0W8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.